Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a clinical stage biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease. The company’s leading product candidate, OCR-002, is currently being studied in phase IIb clinical trials for the treatment of hyperammonemia and resultant hepatic encephalopathy in patients with acute liver failure and acute-on-chronic liver disease. In early testing, OCR-002 has been shown to lower circulating blood levels of ammonia by enabling alternate metabolic pathways in the muscles and kidney, helping the candidate achieve orphan drug designation and fast track status from the FDA.

When commercialized, OCR-002 will provide Ocera with access to a severely underserved market within the biopharmaceutical industry. According to Medscape, acute liver failure, though uncommon, is a debilitating condition in which rapid deterioration of liver function in a previously healthy individual causes encephalopathy, or alteration of mental status, in addition to a host of potentially life-threatening symptoms. Without liver transplantation, the current survival rate of acute liver failure is just seven percent.

In the first quarter of 2015, Ocera ramped up clinical studies of its product pipeline in a push toward the eventual market approval of OCR-002. As of March 31, the company reported cash and cash equivalents of just over $46 million, which will be essential to the continued development of its promising product candidate. Based on its current guidance, Ocera expects that it will have sufficient cash to fund operations into the fourth quarter of 2016.

“I am pleased to report positive developments in our clinical pipeline so far this year, including progress with both the intravenous and oral formulations of OCR-002,” Dr. Linda Grais, president and chief executive officer of Ocera, stated in a news release. “Serious liver disease impacts millions of patients and their families. We at Ocera Therapeutics are committed to finding much needed alternatives to current treatments for these patients.”

The company’s operating strategy includes future licensing of certain rights to its drug development programs following achievement of proof of concept, which should provide Ocera with expanded commercialization capabilities and a limited risk profile while maintaining the potential for significant returns. For prospective shareholders, this strategy could provide a platform for strong financial growth moving forward. Look for Ocera to turn its focus toward the development of strategic industry partnerships as it inches toward the future market approval of OCR-002.

For more information, visit www.ocerainc.com

Liquidmetal Technologies, Inc. (OTC: LQMT) is the world’s leading developer of amorphous alloys, with more than 70 U.S. patents covering its unique manufacturing processes. Unlike metals with crystalline atomic structures, the company’s alloys are distinguished by their ability to retain a random structure following solidification. As the first to produce amorphous alloys in commercially-viable bulk form, Liquidmetal is dramatically changing the way businesses develop new products. The company’s alloys feature a unique atomic structure that opens the door for performance and accuracy levels that exceed the historical limitations of the metal fabrication industry, allowing the company to accurately and consistently produce a broad range of parts for use in medical, military, consumer, industrial and sporting goods products.

In recent months, Liquidmetal has leveraged the versatility of its technology in order to achieve a collection of production milestones. Last month, the company announced the successful delivery of its first production parts made in its recently completed Rancho Santa Margarita manufacturing facility. The product, a hybrid knife that combines the advantages of a fixed blade and a folder, is noteworthy because it is the first of its kind in the world, and its production is only possible using Liquidmetal’s revolutionary technology.

“The first commercial shipments from our newly established Manufacturing Center of Excellence is a hallmark achievement following the establishment of manufacturing, engineering, sales and marketing co-located under one roof,” Tom Steipp, president and chief executive officer of Liquidmetal, stated in a news release. “The success of this project demonstrates the commercial stability of the Liquidmetal process technology.”

Last week, the company built on this progress by announcing the receipt of a prototype order from a world class manufacturer located in Europe. Successful completion of this order, as well as continued increases in marketplace interest surrounding the considerable benefits provided by its proprietary alloy technology, should help Liquidmetal continue expanding its presence in an array of promising industries in the future.

“The success of this recent international prototype order further demonstrates the manufacturing capabilities of our Liquidmetal technology and its growing acceptance on the worldwide stage,” continued Steipp.

Look for Liquidmetal to lean on its sales and marketing team in order to continue identifying marketable customer applications and generating actionable interest in its technology in the months to come.

For more information, visit www.liquidmetal.com

Galenfeha, through its innovative stored energy solutions, is rapidly expanding its market share in a collection of vital industries. In recent weeks, the company has taken tremendous steps toward securing improved financial results through the announcement of broadened oil and gas industry penetration, as well as entry into the aviation industry. These announcements put Galenfeha in a strong strategic position to capitalize on the continued growth of the stored energy market moving forward.

In June, Galenfeha announced a new partnership with leading global resources enterprise BHP Billiton. Through this arrangement, the company will provide its advanced battery systems, including its proprietary CDMA/satellite asset location and tracking technology, to the global oil and gas producer.

“This is an incredibly exciting time for our company,” Lucien Marioneaux, Jr., president and chief executive officer of Galenfeha, stated in a news release. “The opportunity to assist the highly esteemed, global powerhouse firm BHP Billiton is an enormous honor.”

A week later, the company built on this progress when it announced a partnership with Louisiana-based aviation company SkyRunner, LLC. This agreement followed Galenfeha’s successful development of a customized proof-of-concept battery designed to start and power critical onboard systems for use in a new aviation unit. The company’s prototype battery allowed SkyRunner to effectively reduce battery weight by 66 percent and increase cold-cranking amperage by over 266 percent, further demonstrating the versatility and marketability of Galenfeha’s stored energy solutions.

“Galenfeha continually strives to develop relationships with visionary firms such as SkyRunner,” continued Marioneaux. “We are delighted to be selected… to develop a safe, lightweight, ultra-reliable power supply system for [SkyRunner’s] new aircraft.”

Galenfeha’s lithium iron phosphate (LiFePO4) battery is marketed as a light-weight replacement for traditional lead-acid batteries. In addition to providing up to 70 percent reduction in battery mass over conventional lead-acid units, the company’s stored energy offerings deliver up to 40 percent more usable voltage in power-intensive applications. Although specifically developed to improve the efficiency of solar power generation systems, the company has also leveraged its proprietary technology to develop a sustainable presence in a collection of promising markets.

For prospective shareholders, the company’s recent market growth could foreshadow an opportunity for considerable returns in the months to come. Look for Galenfeha to continue building on its progress in expanding the marketability of its advanced battery technology in the future.

Take a closer look at the company by visiting www.galenfeha.com

Let us hear your thoughts: Galenfeha, Inc. Message Board

Thanks to advances in medicine and technology, people are living much longer these days. For many people, this longevity creates an increasing need for proficient at-home care for the highest quality of life, as well as for full recovery following discharge from a medical facility. Selecting a healthcare provider specializing in home-based services can be troublesome and place heavy burden on patients and families. MIT Holding has a simple solution powered by a forward-thinking, visionary management team.

MIT Holding is a single source of high-quality, low cost need-fulfillment for patients provided during their at-home recovery. The company works through its growing network of accredited agents, facilitators and contractual obligations to operate as a single-source provider of professional outpatient medical care including pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies, in addition to home medical equipment for sale or for rent.

The company also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Furthermore, as an accredited healthcare provider, MIT is in full compliance with major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators.

Spearheading this first-of-its-kind business model is a management team of qualified individuals with a shared vision to keep the company at the front-edge of in-home services.

Walter H.C. Drakeford, MIT Holding’s chairman of the board of directors and chief executive officer, has a stellar career that includes the senior managing director of Drakeford & Drakeford for the past 20 years. Since 2007, he has been the director of mergers and acquisitions of AMC Global Communications, Inc. He has also served as chairman of the board for Ebank Financial Services, and has served on the boards of Netstar-USA Corp. and LaidLaw Transportation. Drakeford also served as an attache to the White House under former presidents Nixon, Reagan and George H.W. Bush.

CEO Drakeford began his career with a finance degree from the University of Berlin and a Masters of Business Administration from Heed University, as well as a law degree from Thomas Jefferson School of Law.

Company CFO Robert Yates in 2008 joined MIT Holding as controller. Since 1987, Yates has served as controller or chief financial officer in small-to-medium size firms in Northern California. He received his accounting degree from San Jose State University in 1978 and gained his accounting and auditing experience with Arthur Young & Co. in San Jose, California. Yates obtained his license as a Certified Public Accountant in 1980, and is a veteran who served in the U.S. Air Force in the Vietnam era.

Tommy J. Duncan, president of MIT Holding, became a member of the company’s board of directors in May 2007, and joined the board of directors of Medical Infusion Group in September 2006. Duncan is employed with Southeast Vending, LLC, where he has been president since 2001. He has also been president of Southeast Lumber and Construction, Inc. since 2001.

MIT Holding believes that Duncan has the experience, qualifications, attributes and skills necessary to serve on the board because of his experience in finance, his having provided leadership and strategic direction and knowledge of the company and its business.

Together, this team of professionals has introduced to the healthcare market a much-needed and first-of-its-kind business model that adheres to the changes of the Affordable Care Act and provides patients with unparalleled in-home recovery services.

For more information visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

The rapid proliferation of mobile devices around the world, for which Gartner recently projected 2.8 percent growth this year to over 2.5 billion units being shipped worldwide, has been a major contributing factor to the ongoing state of flux within the payments industry. The fact that active mobile phone accounts now outnumber credit and debit card accounts by over 460 percent, totaling some 7.3 billion (according to information from credit card processer First Data and the International Telecommunications Union), means that for SMEs in particular, the ability to surmount logistical challenges and provide consumers with access to mobile credit and currency will be a major factor in determining their growth potential.

A recent forecast by MarketsandMarkets indicates that the $12.34 billion mobile money market is on track to grow at an impressive 44.6 percent CAGR through 2019, hitting upwards of $78 billion on the strength of continued development in the Asia-Pacific region, as well as Russia, the Middle East, and Africa. However, these regions present persistent cross-border regulatory challenges and complexities related to the nature of emerging markets, complexities like language differences which are increasingly expressed within developed nations like the U.S. and EU as well due to the constantly changing face of the resident populations, as people stream in from countries all over the world.

These underlying market dynamics, which may seem daunting to some in the payments and financial services industry, are bread and butter for an omni-channel PaaS (payments-as-a-service) tech provider like Net Element (NASDAQ: NETE), which already has over 1 million recurring mobile payment subscribers. Through the company’s global mobile payments and transactional processing subsidiary, TOT Group, Inc., Net Element possesses an enviable capacity to on-board businesses and consumers alike through a single interface. This capacity to offer a universalized, highly secure and yet extremely simple means for purchases to be made without a credit card or a bank account has given the company a strong footing in emerging markets such as the Russian Federation.

The recent move to acquire major Russian Federation payment processor PayOnline – which has around 10 million active consumers and also provides payment solutions to thousands of merchants throughout the Russian Federation, as well as in Europe and Asia – is a major milestone for NETE that has further cemented the company’s established presence in these regions. PayOnline recently dropped an SDK for iOS that allows for easy integration of PayOnline transaction processing into iPad and iPhone apps, further opening up the market of over 390 million mobile users in Russia alone, and with one of Russia’s top six airlines, Ural Airlines, being one of the first iOS app clients, NETE already has the ball rolling fast.

A 3-year contract to process transactions for Social Discovery Ventures’ online dating and social networks – including AnastasiaDate, AmoLatina and AsianDate, which have over 4 million registered users and over 150 million visitors each year – is another big win right out of the gate for NETE when it comes to the PayOnline acquisition. This one deal on its own opens up a revenue stream of some $1.2 million over the life of the contract and offers a minimum processing commitment of $300 million.

Leaping over varied banking, demographic and regulatory hurdles, NETE pursues a dynamic vision of leveraging technology to empower consumers, as well as SMEs, when it comes to handling billing and payment acceptance, whether it is via ecommerce and mcommerce pathways, or through traditional card-present transactions. TOT Money’s extensive integration and relationships with mobile operators throughout the Russian Federation region, enhanced by the PayOnline acquisition, which is rapidly being dovetailed into NETE’s existing operational footprint, brings comprehensive mobile payment processing services to this vast and growing mobile market, where PayOnline already sees nearly 20 percent of all online payments being processed via mobile.

Given that this 20 percent figure represents a 157 percent uptick year over year and that over half of all such payments processed were iOS-driven, the company is extremely confident of its ability to garner continued market share regionally and to expand its presence further into neighboring regions. To wit, NETE has launched its payment processing business in Kazakhstan via an agreement with the country’s largest bank, Kazkommertsbank, and secured a key contract with the second biggest online merchant in the country, Kassir.com, which also happens to be Kazakhstan’s number one online events ticketing website.

Take a closer look by visiting www.netelement.com

For the third consecutive year Noble Financial is literally taking over all of Club Med’s palmy 220 acres in Florida to host the Noble 12th Annual Investor Conference, NobleCon.

NobleCon will take place in Sandpiper Bay, Florida, January 17-20, 2016, and will feature 150 presenting companies, 350 qualified investors and 1,200 scheduled meetings.

This “destination” investor conference offers a relatively remote location to allow for ultimate networking opportunities, formal presentations, one-on-one scheduled meetings, lunch/dinner assigned seating, cocktail receptions, panel presentations, educational workshops and evening networking events.

For public and private companies, the conference provides corporate executives a platform to tell their story and meet with investors, Noble analysts, investment bankers and more. But it doesn’t end when the sun goes down. Evening programs and entertainment are specifically designed to stimulate further dialogue.

Attending investors, equity analysts, high net worth individuals, portfolio managers, investment clubs and other attendees will gain valuable investment ideas and unparalleled access to corporate executive teams.

Noble has also lined up an impressive slate of speakers for the 2016 event:

• Dr. Arthur Agatston, author of The South Beach Diet
• James Allen, chairman, president and CEO of Hard Rock International
• Bob Baur, chief global economist, principal global investments
• Richard Blumenthal, senior U.S. senator, Connecticut
• Clyde Harrison, partner of Carl Icahn
• Larry King, radio and television personality
• Robert Pittman, chairman and CEO of iHeartMedia
• Brian Mulroney, 18th prime minister of Canada
• Betty Liu, news anchor, Bloomberg Television
• Mark Gordon, president and CEO of Odyssey Marine Exploration
• Richard Petty, renowned NASCAR race car driver
• Peter Shutz, CEO of Porsche Worldwide

For more information visit www.nobleconference.com

Nyxio Technologies delivers high quality, cutting-edge products to the consumer electronics industry. Since being founded in 2007, the company has grown in its target markets through a relentless dedication to innovation and staying ahead of the technology curve. Nyxio’s flagship product, the VioSphere Genius TV, demonstrates this commitment to innovation, as it was the first fully-integrated flat screen TV and full PC available on the market, and it was released three full years before the consensus determined the overall marketability of the smart TV and related products. By consistently consolidating key hardware components into efficient electronic devices, the company ensures a reasonably priced product line that gives it a strong strategic position within the competitive electronics market.

In recent months, Nyxio has shifted its focus toward mobile solutions through the continued development of its Play Gig-it mobile app. Play Gig-it, which the company acquired last year through the purchase of 212 Decibel, is a groundbreaking gaming app designed to blur the lines between gaming, the music industry, merchandizing and revenue opportunities. Nyxio plans to utilize influencer marketing in order to advertise the app in the future. In April, the company announced a partnership with TopFan, the world’s largest sports and entertainment mobile app developer, which gives Nyxio access to 279 influencers, as well as a whopping 750 million active users.

“Coming from a marketing standpoint, this is a more than substantial place for the company to be, especially in regard to how advertisers can reach celebrities and influence the general masses by associating themselves with a product,” Lorien Sekora, director of marketing at Nyxio, stated in a news release. “As a company, we now have the ability to market to advertisers on an unusually broad scale.”

By establishing a presence in the rapidly expanding mobile app market, Nyxio could be in a strong position to promote financial growth in the months to come, and the company’s marketing strategy could be a powerful catalyst to initializing this development. According a report by Forbes, marketing-inspired word-of-mouth, such as Nyxio’s influencer model, generates more than twice the sales of paid advertising. Additionally, customers attracted with these methods have a 37 percent higher retention rate than those from traditional channels.

For prospective investors, Nyxio’s commitment to innovation within the technology industry makes the company an intriguing investment opportunity moving forward. Look for Nyxio to leverage the marketability of its recent acquisition in order to build upon the market success it’s achieved with its innovative product line.

For more information, visit www.nyxio.com

Saleen Automotive, Inc. (SLNN) Combining Style and Performance to Expand Presence in Automotive Industry

Saleen Automotive is a specialty manufacturer of high performance vehicles, technical performance parts, lifestyle accessories and apparel. By continually setting the bar for automotive design and performance engineering in both street and racing applications, the company has established a presence among the top specialty automotive brands in the world. Saleen currently manufactures a collection of innovative vehicles based on some of the country’s most popular automobile models – including the Ford Mustang, Chevrolet Camaro and Dodge Challenger.

Since its initial release in 1984, Saleen’s performance-based take on the Ford Mustang has been among the company’s most successful and recognizable offerings. In February, Saleen built upon this tradition by shipping the first version of its all-new 302 Mustang. A month later, the company unveiled the 2015 Saleen S302 Black Label, which is hailed as the most powerful production Mustang ever produced. Through the release of these models, Saleen will look to capitalize on what’s expected to be a strong year for the automotive industry, according to Bloomberg.

“These are the best Mustangs I have ever built,” Steve Saleen, chief executive officer of Saleen, stated in a news release. “We are in for a thrill ride as this car will take us to levels we have never seen before.”

In recent months, Saleen has shown versatility in meeting the evolving demands of the automotive industry by entering the electric vehicle market. The company’s all-electric FOURSIXTEEN is based on the Model S by Tesla Motors (NASDAQ: TSLA). With this model, Saleen combines the industry-leading mileage efficiency of Tesla’s original design with an array of features that make the vehicle faster, more stylish and more comfortable for both driver and passengers.

“By dramatically improving the aerodynamics, suspension, braking and drive train we are able to create a car that accelerates quicker with vastly improved handling,” continued Saleen. “It is truly exceptional.”

Last month, the company made significant progress toward improving its financial results when it expanded an existing marketing and distribution agreement with GreenTech Automotive, Inc. to include intellectual property licensing rights. Through this partnership, Saleen will look to introduce its brand and product distribution into the thriving Asian market, providing a channel for potentially massive sales growth moving forward. According to JD Power, China’s automotive market is currently the largest in the world, with more than 19.7 million new cars sold in 2014.

For prospective shareholders, Saleen could represent a rewarding investment opportunity in the months to come. Look for the company to continue leveraging its reputation for style and performance in order to promote strong sales figures in the future.

For more information, visit www.saleenautomotive.com

Curis is a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers. The company’s leading product candidate, CUDC-907, is currently in phase I clinical trials for the treatment of lymphoma and multiple myeloma, as well as solid tumors. Additionally, the company’s product pipeline includes CUDC-427, which is being studied for the treatment of solid tumors and lymphomas, and CUDC-305 for the treatment of cancers.

The company’s most advanced drug, Erivedge®, was developed in collaboration with Genentech, Inc. and is currently approved for use in patients with advanced basal cell carcinoma (BCC) in the United States, the European Union, Australia and a collection of other countries. The potential market for Erivedge is extensive. According to a report by the Skin Cancer Foundation, an estimated 2.8 million patients in the U.S. are diagnosed with BCC annually, making it the most common form of skin cancer. In the first quarter of 2015, Curis recorded $1.7 million in royalty revenues from global sales of the product, representing a 30 percent year-over-year improvement.

In recent months, Curis has made significant progress toward the continued expansion of its promising product pipeline. In January, the company entered into an exclusive collaboration agreement with Aurigene Discovery Technologies Limited focused on the discovery, development and commercialization of small molecule immuno-oncology therapeutics. In the months to come, Curis will have the option to exercise exclusive licensing rights on a selection of drug candidates already in clinical development, providing a platform for strong financial growth.

With an established and growing presence in the immuno-oncology treatment industry, Curis has access to near limitless market potential moving forward. According to investment bank Leerink Swann, the immuno-oncology market is expected to reach a value of approximately $29 billion within the next decade, potentially revolutionizing the treatment options for a wide variety of cancer types along the way.

For prospective investors, Curis’s recent clinical progress could foreshadow an opportunity for improved returns in the coming years. Look for the company to leverage the expanding demand for innovative immuno-oncology treatment options in order to promote continued market growth in the future.

For more information, visit www.curis.com

According to a report by Dodge Data & Analytics, a leading provider of North American construction data, the domestic construction industry is expected to expand by nine percent in 2015, building upon the five percent growth achieved last year. For ENGlobal Corp. (NASDAQ: ENG), this forecast industry performance could provide a platform for improved results through the company’s award-winning engineering and construction division.

ENGlobal’s engineering and construction group delivers a range of innovative, cost-effective automation, instrumentation and specialty construction projects to customers around the planet, particularly in energy market sectors. By offering everything from feasibility studies and conceptual design to turnkey project responsibility, the company has built a formidable presence in the engineering, procurement and construction management (EPCM) market for more than a quarter of a century. With a global reputation for state-of-the-art plant automation systems, ENGlobal has become a mainstay on some of the engineering industry’s most prestigious lists, including Engineering News Record magazine’s ‘Top 500 Engineering Design Firms’, which has listed the company annually for more than a decade.

In recent months, the company has been impacted by the downturn in energy commodity prices, which has affected many of its early 2015 orders. Despite this market turbulence, ENGlobal has remained well-positioned for future expansion by refining its operational focus toward projects with low levels of risk. As of the release of its first quarter results, the company reported a healthy cash balance of more than $24 million, providing the flexibility needed to weather the current market slowdown.

“While there is always room for improvement, I believe we are in a strong financial position and poised for future growth,” Mark Hess, chief financial officer of ENGlobal, stated in a news release. “We have pared the company down to a smaller, more focused operation and reduced the risk profile of the projects we are undertaking… These and other actions have allowed the company to remain profitable, with positive cash flow during this downturn.”

For prospective shareholders, ENGlobal’s versatility in the face of less than ideal market conditions demonstrates the valuable industry experience of its management team and makes the company an intriguing investment opportunity moving forward. Look for ENGlobal to lean on its proven track record of innovative EPCM solutions in order to promote continued industry growth in the months to come.

For more information, visit www.englobal.com